Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 03, 2022

SELL
$1.16 - $2.23 $15,378 - $29,563
-13,257 Closed
0 $0
Q3 2021

Nov 05, 2021

BUY
$2.24 - $4.29 $29,397 - $56,301
13,124 Added 9867.67%
13,257 $30,000
Q4 2020

Feb 04, 2021

SELL
$3.86 - $5.07 $671 - $882
-174 Reduced 56.68%
133 $1,000
Q1 2020

May 14, 2020

BUY
$5.65 - $15.71 $485 - $1,351
86 Added 38.91%
307 $2,000
Q4 2019

Jan 31, 2020

BUY
$10.15 - $15.58 $2,243 - $3,443
221 New
221 $3,000

Others Institutions Holding ORTX

About Orchard Therapeutics plc


  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.